nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—RIPK2—leprosy	0.553	1	CbGaD
Vandetanib—FMO3—Dapsone—leprosy	0.189	0.707	CbGbCtD
Vandetanib—ABCC1—Rifampicin—leprosy	0.0621	0.232	CbGbCtD
Vandetanib—CYP3A4—Rifampicin—leprosy	0.00898	0.0336	CbGbCtD
Vandetanib—CYP3A4—Dapsone—leprosy	0.00741	0.0277	CbGbCtD
Vandetanib—FMO3—sweat—leprosy	0.00643	0.104	CbGeAlD
Vandetanib—Posterior reversible encephalopathy syndrome—Thalidomide—leprosy	0.00318	0.0574	CcSEcCtD
Vandetanib—PTK6—skin epidermis—leprosy	0.00291	0.0472	CbGeAlD
Vandetanib—BMPR1B—peripheral nervous system—leprosy	0.00241	0.0391	CbGeAlD
Vandetanib—Peritonitis—Thalidomide—leprosy	0.00207	0.0373	CcSEcCtD
Vandetanib—ERBB3—peripheral nervous system—leprosy	0.00181	0.0293	CbGeAlD
Vandetanib—PLK4—Menadione—Thalidomide—leprosy	0.00173	1	CbGdCrCtD
Vandetanib—KDR—hindlimb—leprosy	0.0016	0.026	CbGeAlD
Vandetanib—KDR—appendage—leprosy	0.00137	0.0223	CbGeAlD
Vandetanib—Intestinal perforation—Thalidomide—leprosy	0.00132	0.0238	CcSEcCtD
Vandetanib—Dysaesthesia—Thalidomide—leprosy	0.00121	0.0218	CcSEcCtD
Vandetanib—Pericarditis—Thalidomide—leprosy	0.00121	0.0218	CcSEcCtD
Vandetanib—FLT4—blood vessel—leprosy	0.00116	0.0189	CbGeAlD
Vandetanib—Proteinuria—Dapsone—leprosy	0.00116	0.021	CcSEcCtD
Vandetanib—RIPK2—blood vessel—leprosy	0.00116	0.0188	CbGeAlD
Vandetanib—Protein urine present—Dapsone—leprosy	0.00114	0.0207	CcSEcCtD
Vandetanib—Altered state of consciousness—Thalidomide—leprosy	0.00113	0.0204	CcSEcCtD
Vandetanib—Cerebral ischaemia—Thalidomide—leprosy	0.00108	0.0195	CcSEcCtD
Vandetanib—White blood cell count decreased—Thalidomide—leprosy	0.00105	0.0189	CcSEcCtD
Vandetanib—EPHA8—eye—leprosy	0.00104	0.0168	CbGeAlD
Vandetanib—Transient ischaemic attack—Thalidomide—leprosy	0.00103	0.0187	CcSEcCtD
Vandetanib—TEK—blood vessel—leprosy	0.000935	0.0152	CbGeAlD
Vandetanib—PTK6—skin of body—leprosy	0.000901	0.0146	CbGeAlD
Vandetanib—Platelet count decreased—Thalidomide—leprosy	0.000878	0.0158	CcSEcCtD
Vandetanib—Serum creatinine increased—Thalidomide—leprosy	0.000849	0.0153	CcSEcCtD
Vandetanib—SRC—blood vessel—leprosy	0.000831	0.0135	CbGeAlD
Vandetanib—Hypomagnesaemia—Thalidomide—leprosy	0.000822	0.0148	CcSEcCtD
Vandetanib—Hypothyroidism—Thalidomide—leprosy	0.000813	0.0147	CcSEcCtD
Vandetanib—Nail disorder—Thalidomide—leprosy	0.000805	0.0145	CcSEcCtD
Vandetanib—EPHA5—eye—leprosy	0.000802	0.013	CbGeAlD
Vandetanib—KDR—blood vessel—leprosy	0.000765	0.0124	CbGeAlD
Vandetanib—Hypercalcaemia—Thalidomide—leprosy	0.000752	0.0136	CcSEcCtD
Vandetanib—Interstitial lung disease—Thalidomide—leprosy	0.000738	0.0133	CcSEcCtD
Vandetanib—TYRO3—skin of body—leprosy	0.000697	0.0113	CbGeAlD
Vandetanib—Skin ulcer—Thalidomide—leprosy	0.000671	0.0121	CcSEcCtD
Vandetanib—Nasopharyngitis—Dapsone—leprosy	0.000662	0.0119	CcSEcCtD
Vandetanib—PDGFRB—blood vessel—leprosy	0.000662	0.0107	CbGeAlD
Vandetanib—Influenza—Dapsone—leprosy	0.00064	0.0115	CcSEcCtD
Vandetanib—Endocrine disorder—Thalidomide—leprosy	0.00063	0.0114	CcSEcCtD
Vandetanib—Pancreatitis—Dapsone—leprosy	0.000627	0.0113	CcSEcCtD
Vandetanib—Acne—Thalidomide—leprosy	0.000621	0.0112	CcSEcCtD
Vandetanib—FLT4—eye—leprosy	0.000619	0.01	CbGeAlD
Vandetanib—RIPK2—eye—leprosy	0.000616	0.00999	CbGeAlD
Vandetanib—Proteinuria—Thalidomide—leprosy	0.000594	0.0107	CcSEcCtD
Vandetanib—LTK—testis—leprosy	0.000593	0.00961	CbGeAlD
Vandetanib—Protein urine present—Thalidomide—leprosy	0.000586	0.0106	CcSEcCtD
Vandetanib—Photosensitivity reaction—Dapsone—leprosy	0.000584	0.0105	CcSEcCtD
Vandetanib—STK35—skin of body—leprosy	0.000581	0.00942	CbGeAlD
Vandetanib—Cellulitis—Thalidomide—leprosy	0.000574	0.0104	CcSEcCtD
Vandetanib—Hypocalcaemia—Thalidomide—leprosy	0.00057	0.0103	CcSEcCtD
Vandetanib—EPHA8—testis—leprosy	0.000568	0.00922	CbGeAlD
Vandetanib—EPHA8—nervous system—leprosy	0.000558	0.00905	CbGeAlD
Vandetanib—MKNK1—eye—leprosy	0.000553	0.00897	CbGeAlD
Vandetanib—Creatinine increased—Thalidomide—leprosy	0.000549	0.0099	CcSEcCtD
Vandetanib—AXL—eye—leprosy	0.000544	0.00883	CbGeAlD
Vandetanib—RIPK2—skin of body—leprosy	0.000536	0.00869	CbGeAlD
Vandetanib—Sinusitis—Dapsone—leprosy	0.000535	0.00966	CcSEcCtD
Vandetanib—FMO3—eye—leprosy	0.000528	0.00856	CbGeAlD
Vandetanib—ERBB3—skin of body—leprosy	0.000513	0.00832	CbGeAlD
Vandetanib—Depressed level of consciousness—Thalidomide—leprosy	0.000504	0.0091	CcSEcCtD
Vandetanib—Colitis—Thalidomide—leprosy	0.000501	0.00905	CcSEcCtD
Vandetanib—Dry eye—Thalidomide—leprosy	0.000482	0.0087	CcSEcCtD
Vandetanib—EPHA6—testis—leprosy	0.000474	0.00769	CbGeAlD
Vandetanib—AXL—skin of body—leprosy	0.000474	0.00768	CbGeAlD
Vandetanib—PLK4—testis—leprosy	0.000468	0.00759	CbGeAlD
Vandetanib—EPHA6—nervous system—leprosy	0.000465	0.00754	CbGeAlD
Vandetanib—YES1—eye—leprosy	0.00046	0.00746	CbGeAlD
Vandetanib—Sepsis—Thalidomide—leprosy	0.000453	0.00818	CcSEcCtD
Vandetanib—FYN—skin of body—leprosy	0.000443	0.00719	CbGeAlD
Vandetanib—SRC—eye—leprosy	0.000442	0.00717	CbGeAlD
Vandetanib—STK35—tendon—leprosy	0.000442	0.00717	CbGeAlD
Vandetanib—TYRO3—testis—leprosy	0.00044	0.00713	CbGeAlD
Vandetanib—EPHA5—nervous system—leprosy	0.000431	0.007	CbGeAlD
Vandetanib—TYRO3—nervous system—leprosy	0.000431	0.007	CbGeAlD
Vandetanib—ABL2—tendon—leprosy	0.000431	0.00699	CbGeAlD
Vandetanib—BMPR1B—testis—leprosy	0.000431	0.00699	CbGeAlD
Vandetanib—MAP3K19—testis—leprosy	0.000431	0.00699	CbGeAlD
Vandetanib—LYN—nervous system—leprosy	0.000429	0.00696	CbGeAlD
Vandetanib—Gastroenteritis—Thalidomide—leprosy	0.000428	0.00772	CcSEcCtD
Vandetanib—BMPR1B—nervous system—leprosy	0.000423	0.00686	CbGeAlD
Vandetanib—MAP3K19—nervous system—leprosy	0.000423	0.00686	CbGeAlD
Vandetanib—Vision blurred—Dapsone—leprosy	0.00042	0.00758	CcSEcCtD
Vandetanib—EPHB6—skin of body—leprosy	0.000414	0.00671	CbGeAlD
Vandetanib—RIPK2—tendon—leprosy	0.000408	0.00661	CbGeAlD
Vandetanib—KDR—eye—leprosy	0.000407	0.0066	CbGeAlD
Vandetanib—VEGFA—tendon—leprosy	0.000407	0.0066	CbGeAlD
Vandetanib—FMO1—tendon—leprosy	0.000404	0.00656	CbGeAlD
Vandetanib—Atrial fibrillation—Thalidomide—leprosy	0.0004	0.00722	CcSEcCtD
Vandetanib—IRAK4—tendon—leprosy	0.000398	0.00646	CbGeAlD
Vandetanib—Dermatitis bullous—Thalidomide—leprosy	0.000397	0.00716	CcSEcCtD
Vandetanib—Cough—Dapsone—leprosy	0.000389	0.00702	CcSEcCtD
Vandetanib—Cardiac failure—Thalidomide—leprosy	0.000388	0.00701	CcSEcCtD
Vandetanib—Hypoglycaemia—Thalidomide—leprosy	0.000388	0.00701	CcSEcCtD
Vandetanib—Lethargy—Thalidomide—leprosy	0.000387	0.00698	CcSEcCtD
Vandetanib—SRC—skin of body—leprosy	0.000385	0.00624	CbGeAlD
Vandetanib—Hyponatraemia—Thalidomide—leprosy	0.000381	0.00687	CcSEcCtD
Vandetanib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000379	0.00684	CcSEcCtD
Vandetanib—FLT3—testis—leprosy	0.000374	0.00606	CbGeAlD
Vandetanib—STK35—testis—leprosy	0.000366	0.00594	CbGeAlD
Vandetanib—RET—tendon—leprosy	0.000362	0.00587	CbGeAlD
Vandetanib—FGR—tendon—leprosy	0.000362	0.00587	CbGeAlD
Vandetanib—AXL—tendon—leprosy	0.00036	0.00585	CbGeAlD
Vandetanib—Cardiac arrest—Thalidomide—leprosy	0.00036	0.0065	CcSEcCtD
Vandetanib—STK35—nervous system—leprosy	0.000359	0.00583	CbGeAlD
Vandetanib—ABL2—testis—leprosy	0.000357	0.00579	CbGeAlD
Vandetanib—Blood creatinine increased—Thalidomide—leprosy	0.000355	0.00641	CcSEcCtD
Vandetanib—Dehydration—Thalidomide—leprosy	0.000353	0.00636	CcSEcCtD
Vandetanib—PDGFRB—eye—leprosy	0.000352	0.00571	CbGeAlD
Vandetanib—EGFR—testis—leprosy	0.000348	0.00565	CbGeAlD
Vandetanib—Dry skin—Thalidomide—leprosy	0.000347	0.00627	CcSEcCtD
Vandetanib—SLK—tendon—leprosy	0.000347	0.00563	CbGeAlD
Vandetanib—Hypokalaemia—Thalidomide—leprosy	0.000345	0.00623	CcSEcCtD
Vandetanib—FLT4—testis—leprosy	0.000339	0.00551	CbGeAlD
Vandetanib—RIPK2—testis—leprosy	0.000338	0.00548	CbGeAlD
Vandetanib—FYN—tendon—leprosy	0.000337	0.00547	CbGeAlD
Vandetanib—VEGFA—testis—leprosy	0.000337	0.00546	CbGeAlD
Vandetanib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000334	0.00603	CcSEcCtD
Vandetanib—TEK—tendon—leprosy	0.00033	0.00535	CbGeAlD
Vandetanib—MAP4K5—tendon—leprosy	0.00033	0.00535	CbGeAlD
Vandetanib—IRAK4—testis—leprosy	0.00033	0.00535	CbGeAlD
Vandetanib—Insomnia—Dapsone—leprosy	0.000329	0.00594	CcSEcCtD
Vandetanib—FMO1—nervous system—leprosy	0.000329	0.00533	CbGeAlD
Vandetanib—Influenza—Thalidomide—leprosy	0.000328	0.00591	CcSEcCtD
Vandetanib—Dysphagia—Thalidomide—leprosy	0.000328	0.00591	CcSEcCtD
Vandetanib—IRAK4—nervous system—leprosy	0.000324	0.00525	CbGeAlD
Vandetanib—ERBB3—testis—leprosy	0.000323	0.00524	CbGeAlD
Vandetanib—Bronchospasm—Thalidomide—leprosy	0.000322	0.00582	CcSEcCtD
Vandetanib—Pancreatitis—Thalidomide—leprosy	0.000321	0.0058	CcSEcCtD
Vandetanib—ERBB3—nervous system—leprosy	0.000317	0.00514	CbGeAlD
Vandetanib—Bronchitis—Thalidomide—leprosy	0.000315	0.00569	CcSEcCtD
Vandetanib—EPHB6—tendon—leprosy	0.000315	0.00511	CbGeAlD
Vandetanib—ABL1—eye—leprosy	0.000314	0.00509	CbGeAlD
Vandetanib—PDGFRB—skin of body—leprosy	0.000306	0.00497	CbGeAlD
Vandetanib—Neutropenia—Thalidomide—leprosy	0.000306	0.00553	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Thalidomide—leprosy	0.000304	0.0055	CcSEcCtD
Vandetanib—YES1—tendon—leprosy	0.000304	0.00494	CbGeAlD
Vandetanib—MKNK1—testis—leprosy	0.000303	0.00492	CbGeAlD
Vandetanib—Pollakiuria—Thalidomide—leprosy	0.000303	0.00546	CcSEcCtD
Vandetanib—STK10—tendon—leprosy	0.000302	0.00489	CbGeAlD
Vandetanib—FGR—testis—leprosy	0.0003	0.00486	CbGeAlD
Vandetanib—RET—testis—leprosy	0.0003	0.00486	CbGeAlD
Vandetanib—LCK—testis—leprosy	0.0003	0.00486	CbGeAlD
Vandetanib—Photosensitivity reaction—Thalidomide—leprosy	0.000299	0.0054	CcSEcCtD
Vandetanib—AXL—testis—leprosy	0.000298	0.00484	CbGeAlD
Vandetanib—MKNK1—nervous system—leprosy	0.000298	0.00483	CbGeAlD
Vandetanib—Gastrointestinal pain—Dapsone—leprosy	0.000298	0.00537	CcSEcCtD
Vandetanib—Weight decreased—Thalidomide—leprosy	0.000296	0.00535	CcSEcCtD
Vandetanib—Hyperglycaemia—Thalidomide—leprosy	0.000296	0.00533	CcSEcCtD
Vandetanib—FGR—nervous system—leprosy	0.000294	0.00477	CbGeAlD
Vandetanib—RET—nervous system—leprosy	0.000294	0.00477	CbGeAlD
Vandetanib—Pneumonia—Thalidomide—leprosy	0.000294	0.0053	CcSEcCtD
Vandetanib—AXL—nervous system—leprosy	0.000293	0.00475	CbGeAlD
Vandetanib—Infestation—Thalidomide—leprosy	0.000292	0.00527	CcSEcCtD
Vandetanib—Infestation NOS—Thalidomide—leprosy	0.000292	0.00527	CcSEcCtD
Vandetanib—Depression—Thalidomide—leprosy	0.000291	0.00526	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00029	0.00523	CcSEcCtD
Vandetanib—FMO3—testis—leprosy	0.000289	0.00469	CbGeAlD
Vandetanib—Abdominal pain—Dapsone—leprosy	0.000288	0.00519	CcSEcCtD
Vandetanib—Body temperature increased—Dapsone—leprosy	0.000288	0.00519	CcSEcCtD
Vandetanib—SLK—testis—leprosy	0.000287	0.00466	CbGeAlD
Vandetanib—Renal failure—Thalidomide—leprosy	0.000287	0.00518	CcSEcCtD
Vandetanib—Stomatitis—Thalidomide—leprosy	0.000285	0.00514	CcSEcCtD
Vandetanib—FMO3—nervous system—leprosy	0.000284	0.00461	CbGeAlD
Vandetanib—Conjunctivitis—Thalidomide—leprosy	0.000284	0.00512	CcSEcCtD
Vandetanib—FYN—testis—leprosy	0.000279	0.00453	CbGeAlD
Vandetanib—Haematuria—Thalidomide—leprosy	0.000279	0.00503	CcSEcCtD
Vandetanib—Epistaxis—Thalidomide—leprosy	0.000276	0.00497	CcSEcCtD
Vandetanib—FYN—nervous system—leprosy	0.000274	0.00445	CbGeAlD
Vandetanib—Sinusitis—Thalidomide—leprosy	0.000274	0.00495	CcSEcCtD
Vandetanib—ABL1—skin of body—leprosy	0.000273	0.00443	CbGeAlD
Vandetanib—TEK—testis—leprosy	0.000273	0.00443	CbGeAlD
Vandetanib—MAP4K5—testis—leprosy	0.000273	0.00443	CbGeAlD
Vandetanib—KDR—tendon—leprosy	0.000269	0.00437	CbGeAlD
Vandetanib—MAP2K5—tendon—leprosy	0.000269	0.00437	CbGeAlD
Vandetanib—TEK—nervous system—leprosy	0.000268	0.00435	CbGeAlD
Vandetanib—MAP4K5—nervous system—leprosy	0.000268	0.00435	CbGeAlD
Vandetanib—Bradycardia—Thalidomide—leprosy	0.000267	0.00482	CcSEcCtD
Vandetanib—EPHB6—testis—leprosy	0.000261	0.00423	CbGeAlD
Vandetanib—Urinary tract disorder—Thalidomide—leprosy	0.000259	0.00467	CcSEcCtD
Vandetanib—Urethral disorder—Thalidomide—leprosy	0.000257	0.00464	CcSEcCtD
Vandetanib—EPHB6—nervous system—leprosy	0.000256	0.00415	CbGeAlD
Vandetanib—Visual impairment—Thalidomide—leprosy	0.000253	0.00456	CcSEcCtD
Vandetanib—YES1—testis—leprosy	0.000252	0.00409	CbGeAlD
Vandetanib—STK10—testis—leprosy	0.00025	0.00405	CbGeAlD
Vandetanib—Erythema multiforme—Thalidomide—leprosy	0.000248	0.00447	CcSEcCtD
Vandetanib—YES1—nervous system—leprosy	0.000247	0.00401	CbGeAlD
Vandetanib—STK10—nervous system—leprosy	0.000245	0.00398	CbGeAlD
Vandetanib—Eye disorder—Thalidomide—leprosy	0.000245	0.00442	CcSEcCtD
Vandetanib—Cardiac disorder—Thalidomide—leprosy	0.000243	0.00439	CcSEcCtD
Vandetanib—SRC—testis—leprosy	0.000243	0.00393	CbGeAlD
Vandetanib—SRC—nervous system—leprosy	0.000238	0.00386	CbGeAlD
Vandetanib—Angiopathy—Thalidomide—leprosy	0.000238	0.00429	CcSEcCtD
Vandetanib—Mediastinal disorder—Thalidomide—leprosy	0.000236	0.00427	CcSEcCtD
Vandetanib—Arrhythmia—Thalidomide—leprosy	0.000234	0.00423	CcSEcCtD
Vandetanib—PDGFRB—tendon—leprosy	0.000233	0.00378	CbGeAlD
Vandetanib—Alopecia—Thalidomide—leprosy	0.000232	0.00418	CcSEcCtD
Vandetanib—Vomiting—Dapsone—leprosy	0.000231	0.00418	CcSEcCtD
Vandetanib—Mental disorder—Thalidomide—leprosy	0.00023	0.00415	CcSEcCtD
Vandetanib—Malnutrition—Thalidomide—leprosy	0.000228	0.00412	CcSEcCtD
Vandetanib—Headache—Dapsone—leprosy	0.000228	0.00411	CcSEcCtD
Vandetanib—Dysgeusia—Thalidomide—leprosy	0.000224	0.00403	CcSEcCtD
Vandetanib—KDR—testis—leprosy	0.000223	0.00362	CbGeAlD
Vandetanib—MAP2K5—testis—leprosy	0.000223	0.00362	CbGeAlD
Vandetanib—Muscle spasms—Thalidomide—leprosy	0.000219	0.00396	CcSEcCtD
Vandetanib—MAP2K5—nervous system—leprosy	0.000219	0.00355	CbGeAlD
Vandetanib—KDR—nervous system—leprosy	0.000219	0.00355	CbGeAlD
Vandetanib—Nausea—Dapsone—leprosy	0.000216	0.0039	CcSEcCtD
Vandetanib—Vision blurred—Thalidomide—leprosy	0.000215	0.00388	CcSEcCtD
Vandetanib—Tremor—Thalidomide—leprosy	0.000214	0.00386	CcSEcCtD
Vandetanib—ABL1—tendon—leprosy	0.000208	0.00337	CbGeAlD
Vandetanib—Loss of consciousness—Thalidomide—leprosy	0.000201	0.00362	CcSEcCtD
Vandetanib—Cough—Thalidomide—leprosy	0.000199	0.0036	CcSEcCtD
Vandetanib—Convulsion—Thalidomide—leprosy	0.000198	0.00357	CcSEcCtD
Vandetanib—Hypertension—Thalidomide—leprosy	0.000197	0.00356	CcSEcCtD
Vandetanib—Chest pain—Thalidomide—leprosy	0.000194	0.00351	CcSEcCtD
Vandetanib—Arthralgia—Thalidomide—leprosy	0.000194	0.00351	CcSEcCtD
Vandetanib—Anxiety—Thalidomide—leprosy	0.000194	0.0035	CcSEcCtD
Vandetanib—PDGFRB—testis—leprosy	0.000193	0.00313	CbGeAlD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000193	0.00348	CcSEcCtD
Vandetanib—Dry mouth—Thalidomide—leprosy	0.00019	0.00343	CcSEcCtD
Vandetanib—PDGFRB—nervous system—leprosy	0.00019	0.00307	CbGeAlD
Vandetanib—Oedema—Thalidomide—leprosy	0.000186	0.00336	CcSEcCtD
Vandetanib—Infection—Thalidomide—leprosy	0.000185	0.00334	CcSEcCtD
Vandetanib—Nervous system disorder—Thalidomide—leprosy	0.000183	0.0033	CcSEcCtD
Vandetanib—Thrombocytopenia—Thalidomide—leprosy	0.000182	0.00329	CcSEcCtD
Vandetanib—Skin disorder—Thalidomide—leprosy	0.000181	0.00327	CcSEcCtD
Vandetanib—ORM1—nervous system—leprosy	0.000178	0.00288	CbGeAlD
Vandetanib—ABL1—testis—leprosy	0.000172	0.00279	CbGeAlD
Vandetanib—Musculoskeletal discomfort—Thalidomide—leprosy	0.00017	0.00306	CcSEcCtD
Vandetanib—ABL1—nervous system—leprosy	0.000169	0.00274	CbGeAlD
Vandetanib—Insomnia—Thalidomide—leprosy	0.000169	0.00304	CcSEcCtD
Vandetanib—Paraesthesia—Thalidomide—leprosy	0.000167	0.00302	CcSEcCtD
Vandetanib—Dyspnoea—Thalidomide—leprosy	0.000166	0.003	CcSEcCtD
Vandetanib—Dyspepsia—Thalidomide—leprosy	0.000164	0.00296	CcSEcCtD
Vandetanib—Decreased appetite—Thalidomide—leprosy	0.000162	0.00292	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Thalidomide—leprosy	0.000161	0.0029	CcSEcCtD
Vandetanib—Fatigue—Thalidomide—leprosy	0.000161	0.0029	CcSEcCtD
Vandetanib—Constipation—Thalidomide—leprosy	0.000159	0.00288	CcSEcCtD
Vandetanib—Pain—Thalidomide—leprosy	0.000159	0.00288	CcSEcCtD
Vandetanib—ALB—testis—leprosy	0.000159	0.00258	CbGeAlD
Vandetanib—ABCC1—tendon—leprosy	0.000158	0.00257	CbGeAlD
Vandetanib—Gastrointestinal pain—Thalidomide—leprosy	0.000152	0.00275	CcSEcCtD
Vandetanib—Body temperature increased—Thalidomide—leprosy	0.000147	0.00266	CcSEcCtD
Vandetanib—Abdominal pain—Thalidomide—leprosy	0.000147	0.00266	CcSEcCtD
Vandetanib—Asthenia—Thalidomide—leprosy	0.000134	0.00241	CcSEcCtD
Vandetanib—Pruritus—Thalidomide—leprosy	0.000132	0.00238	CcSEcCtD
Vandetanib—ABCC1—testis—leprosy	0.000131	0.00213	CbGeAlD
Vandetanib—Diarrhoea—Thalidomide—leprosy	0.000127	0.0023	CcSEcCtD
Vandetanib—Dizziness—Thalidomide—leprosy	0.000123	0.00222	CcSEcCtD
Vandetanib—Vomiting—Thalidomide—leprosy	0.000118	0.00214	CcSEcCtD
Vandetanib—Rash—Thalidomide—leprosy	0.000117	0.00212	CcSEcCtD
Vandetanib—Dermatitis—Thalidomide—leprosy	0.000117	0.00212	CcSEcCtD
Vandetanib—Headache—Thalidomide—leprosy	0.000117	0.00211	CcSEcCtD
Vandetanib—Nausea—Thalidomide—leprosy	0.000111	0.002	CcSEcCtD
Vandetanib—ABCG2—testis—leprosy	0.000109	0.00176	CbGeAlD
Vandetanib—CYP3A4—nervous system—leprosy	7.42e-05	0.0012	CbGeAlD
Vandetanib—IRAK4—Immune System—CD40LG—leprosy	2.88e-05	0.000473	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—TLR2—leprosy	2.86e-05	0.00047	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—RIPK2—leprosy	2.86e-05	0.00047	CbGpPWpGaD
Vandetanib—FYN—Platelet activation, signaling and aggregation—IL2—leprosy	2.86e-05	0.00047	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—CD8A—leprosy	2.84e-05	0.000468	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—TNF—leprosy	2.81e-05	0.000462	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—CD4—leprosy	2.8e-05	0.000461	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—RIPK2—leprosy	2.76e-05	0.000453	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—TLR2—leprosy	2.76e-05	0.000453	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—RIPK2—leprosy	2.75e-05	0.000452	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PARK2—leprosy	2.74e-05	0.000451	CbGpPWpGaD
Vandetanib—ALB—Folate Metabolism—TNF—leprosy	2.72e-05	0.000448	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—NOD2—leprosy	2.71e-05	0.000446	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—IFNG—leprosy	2.7e-05	0.000444	CbGpPWpGaD
Vandetanib—PDGFRB—MAPK Signaling Pathway—TNF—leprosy	2.69e-05	0.000442	CbGpPWpGaD
Vandetanib—LYN—Immune System—PARK2—leprosy	2.69e-05	0.000442	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PARK2—leprosy	2.67e-05	0.00044	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—HLA-DRB1—leprosy	2.67e-05	0.00044	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—IFNG—leprosy	2.66e-05	0.000438	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—RIPK2—leprosy	2.65e-05	0.000435	CbGpPWpGaD
Vandetanib—FYN—Immune System—PARK2—leprosy	2.65e-05	0.000435	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—TNF—leprosy	2.64e-05	0.000434	CbGpPWpGaD
Vandetanib—LCK—HIV Infection—CD4—leprosy	2.63e-05	0.000433	CbGpPWpGaD
Vandetanib—YES1—Immune System—TLR2—leprosy	2.63e-05	0.000432	CbGpPWpGaD
Vandetanib—YES1—Immune System—RIPK2—leprosy	2.63e-05	0.000432	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD40LG—leprosy	2.6e-05	0.000428	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—NOD2—leprosy	2.59e-05	0.000426	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CYLD—leprosy	2.59e-05	0.000425	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD8A—leprosy	2.57e-05	0.000423	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—CD4—leprosy	2.54e-05	0.000417	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—SLC11A1—leprosy	2.53e-05	0.000417	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD40LG—leprosy	2.53e-05	0.000416	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD40LG—leprosy	2.5e-05	0.000412	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD8A—leprosy	2.5e-05	0.000411	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—NOD2—leprosy	2.5e-05	0.000411	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—SDHD—leprosy	2.49e-05	0.00041	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD40LG—leprosy	2.49e-05	0.00041	CbGpPWpGaD
Vandetanib—LCK—Immune System—CYLD—leprosy	2.49e-05	0.00041	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—IL2—leprosy	2.49e-05	0.000409	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD40LG—leprosy	2.48e-05	0.000407	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD8A—leprosy	2.47e-05	0.000407	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD8A—leprosy	2.47e-05	0.000406	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD8A—leprosy	2.45e-05	0.000402	CbGpPWpGaD
Vandetanib—FYN—Disease—SLC11A1—leprosy	2.44e-05	0.000402	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—TLR2—leprosy	2.44e-05	0.000401	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—RIPK2—leprosy	2.44e-05	0.000401	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD40LG—leprosy	2.44e-05	0.000401	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—CD4—leprosy	2.44e-05	0.000401	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—CD4—leprosy	2.43e-05	0.0004	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD8A—leprosy	2.41e-05	0.000396	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—IL2—leprosy	2.4e-05	0.000395	CbGpPWpGaD
Vandetanib—YES1—Immune System—NOD2—leprosy	2.38e-05	0.000392	CbGpPWpGaD
Vandetanib—LCK—Platelet activation, signaling and aggregation—IL2—leprosy	2.38e-05	0.000391	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.36e-05	0.000389	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—IL2—leprosy	2.36e-05	0.000389	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—RIPK2—leprosy	2.34e-05	0.000385	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—CD4—leprosy	2.34e-05	0.000385	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—HLA-DRB1—leprosy	2.32e-05	0.000381	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD40LG—leprosy	2.29e-05	0.000377	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PARK2—leprosy	2.29e-05	0.000376	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD8A—leprosy	2.27e-05	0.000373	CbGpPWpGaD
Vandetanib—EGFR—MAPK Signaling Pathway—TNF—leprosy	2.24e-05	0.000368	CbGpPWpGaD
Vandetanib—ABCC1—Disease—SLC11A1—leprosy	2.24e-05	0.000368	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—CD4—leprosy	2.24e-05	0.000368	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—IFNG—leprosy	2.22e-05	0.000364	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—NOD2—leprosy	2.21e-05	0.000364	CbGpPWpGaD
Vandetanib—SRC—Immune System—CYLD—leprosy	2.21e-05	0.000363	CbGpPWpGaD
Vandetanib—LCK—Immune System—PARK2—leprosy	2.2e-05	0.000362	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—SDHD—leprosy	2.19e-05	0.000361	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	2.17e-05	0.000357	CbGpPWpGaD
Vandetanib—ALB—Selenium Micronutrient Network—TNF—leprosy	2.16e-05	0.000356	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—CD4—leprosy	2.15e-05	0.000353	CbGpPWpGaD
Vandetanib—EGFR—Disease—SLC11A1—leprosy	2.11e-05	0.000347	CbGpPWpGaD
Vandetanib—SRC—Platelet activation, signaling and aggregation—IL2—leprosy	2.11e-05	0.000346	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD40LG—leprosy	2.11e-05	0.000346	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—HLA-DRB1—leprosy	2.09e-05	0.000344	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD8A—leprosy	2.08e-05	0.000342	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—IL2—leprosy	2.08e-05	0.000342	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	2.04e-05	0.000335	CbGpPWpGaD
Vandetanib—LCK—Disease—SLC11A1—leprosy	2.03e-05	0.000334	CbGpPWpGaD
Vandetanib—MKNK1—Disease—CD4—leprosy	2.03e-05	0.000334	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD40LG—leprosy	2.03e-05	0.000334	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.02e-05	0.000332	CbGpPWpGaD
Vandetanib—BLK—Immune System—HLA-DRB1—leprosy	2.02e-05	0.000331	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD40LG—leprosy	2.01e-05	0.000331	CbGpPWpGaD
Vandetanib—FGR—Immune System—HLA-DRB1—leprosy	2.01e-05	0.00033	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—RIPK2—leprosy	2.01e-05	0.00033	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—IL2—leprosy	2.01e-05	0.00033	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD8A—leprosy	2.01e-05	0.00033	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—RIPK2—leprosy	2e-05	0.000329	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—TLR2—leprosy	2e-05	0.000329	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-DRB1—leprosy	1.99e-05	0.000328	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD8A—leprosy	1.99e-05	0.000327	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	1.97e-05	0.000324	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—CD4—leprosy	1.96e-05	0.000323	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-DRB1—leprosy	1.96e-05	0.000323	CbGpPWpGaD
Vandetanib—LYN—Immune System—RIPK2—leprosy	1.96e-05	0.000322	CbGpPWpGaD
Vandetanib—LYN—Immune System—TLR2—leprosy	1.96e-05	0.000322	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—RIPK2—leprosy	1.96e-05	0.000322	CbGpPWpGaD
Vandetanib—SRC—Immune System—PARK2—leprosy	1.95e-05	0.000321	CbGpPWpGaD
Vandetanib—ABL1—Immune System—RIPK2—leprosy	1.95e-05	0.000321	CbGpPWpGaD
Vandetanib—ABL1—Immune System—TLR2—leprosy	1.95e-05	0.000321	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—RIPK2—leprosy	1.93e-05	0.000318	CbGpPWpGaD
Vandetanib—FYN—Immune System—RIPK2—leprosy	1.93e-05	0.000317	CbGpPWpGaD
Vandetanib—FYN—Immune System—TLR2—leprosy	1.93e-05	0.000317	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—IL2—leprosy	1.89e-05	0.00031	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—CD4—leprosy	1.89e-05	0.00031	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DRB1—leprosy	1.85e-05	0.000304	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—NOD2—leprosy	1.81e-05	0.000298	CbGpPWpGaD
Vandetanib—SRC—Disease—SLC11A1—leprosy	1.8e-05	0.000296	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD40LG—leprosy	1.8e-05	0.000295	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD8A—leprosy	1.78e-05	0.000292	CbGpPWpGaD
Vandetanib—LYN—Immune System—NOD2—leprosy	1.78e-05	0.000292	CbGpPWpGaD
Vandetanib—ABL1—Immune System—NOD2—leprosy	1.77e-05	0.000291	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—RIPK2—leprosy	1.76e-05	0.000289	CbGpPWpGaD
Vandetanib—FYN—Immune System—NOD2—leprosy	1.75e-05	0.000288	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—IL2—leprosy	1.73e-05	0.000284	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.72e-05	0.000283	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—TNF—leprosy	1.72e-05	0.000282	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—RIPK2—leprosy	1.7e-05	0.000279	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DRB1—leprosy	1.69e-05	0.000279	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—IFNG—leprosy	1.69e-05	0.000278	CbGpPWpGaD
Vandetanib—EGFR—Immune System—TLR2—leprosy	1.67e-05	0.000274	CbGpPWpGaD
Vandetanib—EGFR—Immune System—RIPK2—leprosy	1.67e-05	0.000274	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—CD4—leprosy	1.63e-05	0.000269	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	1.63e-05	0.000269	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DRB1—leprosy	1.62e-05	0.000267	CbGpPWpGaD
Vandetanib—LCK—Immune System—RIPK2—leprosy	1.61e-05	0.000264	CbGpPWpGaD
Vandetanib—LCK—Immune System—TLR2—leprosy	1.61e-05	0.000264	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—IL2—leprosy	1.58e-05	0.00026	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—TNF—leprosy	1.54e-05	0.000254	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD40LG—leprosy	1.53e-05	0.000252	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IFNG—leprosy	1.53e-05	0.000252	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD8A—leprosy	1.52e-05	0.000249	CbGpPWpGaD
Vandetanib—EGFR—Immune System—NOD2—leprosy	1.51e-05	0.000248	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—IL2—leprosy	1.5e-05	0.000247	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD40LG—leprosy	1.5e-05	0.000247	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—IL2—leprosy	1.5e-05	0.000246	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—CD4—leprosy	1.5e-05	0.000246	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD40LG—leprosy	1.49e-05	0.000246	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—TNF—leprosy	1.49e-05	0.000245	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—IL2—leprosy	1.49e-05	0.000245	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD8A—leprosy	1.48e-05	0.000244	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD40LG—leprosy	1.48e-05	0.000243	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD8A—leprosy	1.48e-05	0.000243	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD4—leprosy	1.48e-05	0.000243	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—IL2—leprosy	1.47e-05	0.000242	CbGpPWpGaD
Vandetanib—BLK—Immune System—IFNG—leprosy	1.47e-05	0.000242	CbGpPWpGaD
Vandetanib—FGR—Immune System—IFNG—leprosy	1.47e-05	0.000241	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—CD4—leprosy	1.46e-05	0.000241	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD8A—leprosy	1.46e-05	0.00024	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—CD4—leprosy	1.46e-05	0.00024	CbGpPWpGaD
Vandetanib—LCK—Immune System—NOD2—leprosy	1.46e-05	0.000239	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DRB1—leprosy	1.45e-05	0.000238	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—CD4—leprosy	1.44e-05	0.000237	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD4—leprosy	1.44e-05	0.000236	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	1.42e-05	0.000234	CbGpPWpGaD
Vandetanib—SRC—Immune System—RIPK2—leprosy	1.42e-05	0.000234	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD4—leprosy	1.42e-05	0.000234	CbGpPWpGaD
Vandetanib—SRC—Immune System—TLR2—leprosy	1.42e-05	0.000234	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD4—leprosy	1.42e-05	0.000233	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD4—leprosy	1.41e-05	0.000231	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD4—leprosy	1.38e-05	0.000228	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL2—leprosy	1.36e-05	0.000224	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SDHD—leprosy	1.35e-05	0.000223	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IFNG—leprosy	1.35e-05	0.000222	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL2—leprosy	1.31e-05	0.000215	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL2—leprosy	1.31e-05	0.000215	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL2—leprosy	1.3e-05	0.000214	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD4—leprosy	1.3e-05	0.000214	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RIPK2—leprosy	1.29e-05	0.000213	CbGpPWpGaD
Vandetanib—SRC—Immune System—NOD2—leprosy	1.29e-05	0.000212	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD40LG—leprosy	1.28e-05	0.00021	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RIPK2—leprosy	1.27e-05	0.000208	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD8A—leprosy	1.26e-05	0.000208	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RIPK2—leprosy	1.25e-05	0.000205	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—CD4—leprosy	1.25e-05	0.000205	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DRB1—leprosy	1.23e-05	0.000203	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD40LG—leprosy	1.23e-05	0.000202	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—IL2—leprosy	1.23e-05	0.000202	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD8A—leprosy	1.22e-05	0.0002	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DRB1—leprosy	1.21e-05	0.000199	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DRB1—leprosy	1.2e-05	0.000198	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CD4—leprosy	1.2e-05	0.000198	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CD4—leprosy	1.2e-05	0.000197	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL2—leprosy	1.2e-05	0.000197	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD4—leprosy	1.2e-05	0.000197	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DRB1—leprosy	1.19e-05	0.000196	CbGpPWpGaD
Vandetanib—YES1—Immune System—IFNG—leprosy	1.18e-05	0.000195	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD4—leprosy	1.15e-05	0.000189	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD4—leprosy	1.14e-05	0.000188	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TNF—leprosy	1.11e-05	0.000183	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TNF—leprosy	1.11e-05	0.000182	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TNF—leprosy	1.09e-05	0.00018	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD40LG—leprosy	1.09e-05	0.000179	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—IL2—leprosy	1.09e-05	0.000179	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD8A—leprosy	1.08e-05	0.000177	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RIPK2—leprosy	1.08e-05	0.000177	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CD4—leprosy	1.06e-05	0.000175	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL2—leprosy	1.05e-05	0.000173	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RIPK2—leprosy	1.04e-05	0.000171	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DRB1—leprosy	1.03e-05	0.000169	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD4—leprosy	1.02e-05	0.000168	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DRB1—leprosy	9.91e-06	0.000163	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TNF—leprosy	9.45e-06	0.000155	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RIPK2—leprosy	9.19e-06	0.000151	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IFNG—leprosy	9.02e-06	0.000148	CbGpPWpGaD
Vandetanib—LYN—Immune System—IFNG—leprosy	8.83e-06	0.000145	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL2—leprosy	8.79e-06	0.000145	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IFNG—leprosy	8.79e-06	0.000145	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DRB1—leprosy	8.77e-06	0.000144	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD4—leprosy	8.71e-06	0.000143	CbGpPWpGaD
Vandetanib—FYN—Immune System—IFNG—leprosy	8.69e-06	0.000143	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD4—leprosy	8.53e-06	0.00014	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD4—leprosy	8.49e-06	0.00014	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD4—leprosy	8.39e-06	0.000138	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—leprosy	8.06e-06	0.000133	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—leprosy	8.04e-06	0.000132	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL2—leprosy	8.04e-06	0.000132	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL2—leprosy	8.01e-06	0.000132	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL2—leprosy	7.84e-06	0.000129	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL2—leprosy	7.83e-06	0.000129	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL2—leprosy	7.81e-06	0.000128	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—leprosy	7.75e-06	0.000127	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL2—leprosy	7.75e-06	0.000127	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—leprosy	7.72e-06	0.000127	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—leprosy	7.51e-06	0.000123	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—leprosy	7.33e-06	0.000121	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SDHD—leprosy	7.31e-06	0.00012	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—leprosy	7.3e-06	0.00012	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—leprosy	7.25e-06	0.000119	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—leprosy	7.24e-06	0.000119	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—leprosy	7.1e-06	0.000117	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—leprosy	7.04e-06	0.000116	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—leprosy	6.99e-06	0.000115	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—leprosy	6.8e-06	0.000112	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—leprosy	6.7e-06	0.00011	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—leprosy	6.67e-06	0.00011	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—leprosy	6.45e-06	0.000106	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—leprosy	6.43e-06	0.000106	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—leprosy	6.41e-06	0.000105	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—leprosy	6.19e-06	0.000102	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—leprosy	5.71e-06	9.39e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—leprosy	5.69e-06	9.36e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—leprosy	5.18e-06	8.52e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—leprosy	5.07e-06	8.34e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—leprosy	4.99e-06	8.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—leprosy	4.31e-06	7.09e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—leprosy	4.16e-06	6.84e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—leprosy	3.68e-06	6.05e-05	CbGpPWpGaD
